RXi Pharmaceuticals (RXII) Jumps: Stock Moves 11.4% Higher
RXi Pharmaceuticals Corporation (RXII) was a big mover last session with its shares rising over 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock has gained nearly 34% in the past one-month time frame.
This biotechnology company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
RXi Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Investors interested in the Med-Drugs industry may consider better-ranked stocks like Mallinckrodt plc (MNK), Lannett Company, Inc. (LCI) and Endo International plc (ENDP). All the three stocks sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
RXI PHARMACEUTICALS CORP (RXII): Free Stock Analysis Report
MALLINCKRODT PUBLIC LTD CO (MNK): Free Stock Analysis Report
LANNETT COMP (LCI): Free Stock Analysis Report
ENDO INTERNATIONAL PLC ORD (ENDP): Free Stock Analysis Report
Zacks Investment Research